Children and Young People's Gender Incongruence Services - Phase 2

Concepts

• health and social work
• leicester
• specialised services
• new services
• children
• gender incongruence
• young people
• young
• gender
• people

Location

Bristol Royal Hospital for Children (part of University Hospitals Bristol and Weston NHS Foundation Trust)

Description

Provision for the reconfiguration of specialised services for children and young people with gender incongruence, in line with the recommendations of the independent Cass Review, published in February 2022. This work necessitated the decommissioning of the Gender Identity Development Service at the Tavistock and Portman NHS Foundation Trust in March 2024, and the establishment of new services from April 2024 via a phased approach. The contract value for 7 years is £45,920,000. Engagement with providers commenced in July 2022 and therefore falls under the scope of PCR 2015.

Total Quantity or Scope

Award of a contract without prior publication of a call for competition in the cases listed below • The procurement falls outside the scope of application of the regulations Explanation: Only capable providers on the basis these services should be hosted by NHS paediatric tertiary units with strong academic and research functions - this narrows provider selection to organisations that host dedicated children's hospitals. NHS England confirmed that the recommendations would be enacted and engagement with the provider market commenced in July 2022 to identify capable providers for both Phase 1 and 2.

Award Detail

Renewal Options

Contract extension

CPV Codes

• 85000000 - Health and social work services

Indicators

• Options are available.

Legal Justification

Award of a contract without prior publication of a call for competition in the cases listed below • The procurement falls outside the scope of application of the regulations Explanation: Provision for the reconfiguration of specialised services for children and young people with gender incongruence, in line with the recommendations of the independent Cass Review, published in February 2022. Engagement with providers commenced in July 2022 under PCR 2015.